imatinib mesylate

Poland

Drugs containing this active substance

  • IMATENIL

    The medicine is used in adults and children for the treatment of, among others, chronic myeloid leukemia, acute lymphoblastic leukemia with the Philadelphia chromosome, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, and dermatofibrosarcoma protuberans.

    Form: tablets, film-coated

    Active substance Dosage
    imatinib mesylate 477.84 mg

    ATC: L01XE01

    Manufacturer: Biofarm Sp. z o.o.

  • NIBIX

    The medicine is used for the treatment of adults and children with chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

    Form: capsules, hard

    Active substance Dosage
    imatinib mesylate 100 mg

    ATC: L01EA01

    Manufacturer: Adamed Pharma S.A.

  • NIBIX

    The medicine is used for the treatment of adults and children with chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

    Form: capsules, hard

    Active substance Dosage
    imatinib mesylate 400 mg

    ATC: L01EA01

    Manufacturer: Adamed Pharma S.A.